ESR1 and breast carcinoma: In addition, there is a strong and significant quantitative difference in DKK1 expression between A-ROD–positive and A-ROD–negative samples (Fig. 2e), and a significant correlation between DKK1 and A-ROD expression across a panel of both ERa-positive and ERa-negative breast cancer samples (Fig. 2f).